Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)

被引:0
|
作者
Zambrano, M. D. C. Beato [1 ]
Lemaire, A. [2 ]
Montesarchio, V. [3 ]
Sabate, J-M. [4 ]
Serna i Mont-Ros, J. [5 ]
Namane, R. [6 ]
Baccarelli, S. Martin [7 ]
Rico-Villademoros, F. [8 ]
Cobo, M. [9 ]
机构
[1] Hosp Univ Jerez, Oncol Med, Jerez de la Frontera, Spain
[2] Valenciennes Gen Hosp, Oncol & Med Specialties Dept, Valenciennes, France
[3] Monaldi Hosp, Pneumol & Oncol, Naples, Italy
[4] Hop Avicenne, AP HP, Gastroenterol & Digest Oncol, Bobigny, France
[5] Hosp Univ Barcelona, Oncol, Campus Vall Hebron, Barcelona, Spain
[6] Kyowa Kirin Pharma SAS, Med Affairs, Neuilly Sur Seine, France
[7] Apices Soluc SL, Stat, Pinto, Spain
[8] Apices Soluc SL, Med, Pinto, Spain
[9] Hospit Univ Reg & Virgen Victoria Malaga, Med Oncol, IBIMA Inst Invest Biomed Malaga, Malaga, Spain
关键词
D O I
10.1016/j.annonc.2023.09.861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2079P
引用
收藏
页码:S1094 / S1094
页数:1
相关论文
共 50 条
  • [21] Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility
    Lawson, Richard
    King, Frederic
    Marsh, Kevin
    Altincatal, Arman
    Cimen, Ali
    ADVANCES IN THERAPY, 2016, 33 (08) : 1331 - 1346
  • [22] Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients’ Health State Utility
    Richard Lawson
    Frederic King
    Kevin Marsh
    Arman Altincatal
    Ali Cimen
    Advances in Therapy, 2016, 33 : 1331 - 1346
  • [23] Naloxegol: A Review of Its Use in Patients with Opioid-Induced Constipation
    Garnock-Jones, Karly P.
    DRUGS, 2015, 75 (04) : 419 - 425
  • [24] Naloxegol: A Review of Its Use in Patients with Opioid-Induced Constipation
    Karly P. Garnock-Jones
    Drugs, 2015, 75 : 419 - 425
  • [25] Real world experience of naloxegol in treating opioid induced constipation
    Farmer, A.
    Ruffle, J.
    Holt, C. Bruckner
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [26] Naloxegol for Treatment of Opioid-Induced Constipation in the Pediatric Intensive Care Unit
    Gillett, Ethan L. L.
    Layes, Clint A. A.
    Crawley, Lee
    Schexnayder, Stephen M. M.
    CLINICAL PEDIATRICS, 2023, 62 (07) : 721 - 724
  • [27] Naloxegol for Treatment of Opioid-Induced Constipation in the Pediatric Intensive Care Unit
    Gillett, Ethan
    Layes, Clint
    Crawley, Lee
    Schexnayder, Stephen
    PEDIATRICS, 2021, 147 (03)
  • [28] Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem
    Yoon, Stephanie C.
    Bruner, Heather C.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1265 - 1271
  • [29] Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients
    Tobben, Daniel
    Carpenter, Sheniece
    Kolar, Rachel
    Merritt, Tyler
    Young, Tramaine
    Hauser, Paloma
    Collier, Tia
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (07) : 678 - 684
  • [30] Naloxegol Provides Clinically Meaningful Symptom Improvement (PAC-SYM) in Patients With Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
    Brenner, Darren M.
    Rockett, Carol
    Jamindar, Mansi
    Bortey, Enoch
    Almenoff, June
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S129 - S130